ANNA GRAY: Open Payments
NPI 1083198584 · CAIRO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 15 payments from 8 companies in 2025. Trend: 2023 $143 · 2024 $381 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $99 |
| SANOFI-AVENTIS U.S. LLC | 3 | $68 |
| Corcept Therapeutics | 2 | $40 |
| Exact Sciences Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: TRELEGY ELLIPTA, TZIELD, Korlym, Cologuard Collection Kit, Kerendia, MOUNJARO, PREVNAR 20, FARXIGA.
Industry payments across GA — which companies pay providers there.
